Clinical trials
Hematologic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
148 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 20 |
| 2022 | 18 |
| 2023 | 20 |
| 2024 | 16 |
| 2025 | 18 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 45 |
| Recruiting | 43 |
| Completed | 27 |
| Not yet recruiting | 18 |
| Active, not recruiting | 8 |
| Terminated | 5 |
| Suspended | 1 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 8 |
| First Affiliated Hospital of Zhejiang University | 6 |
| Institute of Hematology & Blood Diseases Hospital, China | 5 |
| Nanfang Hospital, Southern Medical University | 5 |
| Ruijin Hospital | 5 |
| Zhejiang University | 5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 4 |
| Peking University People's Hospital | 4 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 4 |
| The First Affiliated Hospital of Soochow University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 148 |
| Recurrence | 21 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Leukemia, Myeloid, Acute | 10 |
| Lymphoma | 10 |
| Multiple Myeloma | 10 |
| Lymphoma, Mantle-Cell | 8 |
| Neoplasms | 8 |
| Hematologic Diseases | 7 |
| Leukemia | 7 |
Trials
Showing 51 to 75 of 148. Each trial links to its page on Pharma Observatory.
48 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.